1.27
-0.02(-1.55%)
Currency In USD
| Previous Close | 1.29 |
| Open | 1.29 |
| Day High | 1.29 |
| Day Low | 1.27 |
| 52-Week High | 1.5 |
| 52-Week Low | 0.91 |
| Volume | 65,367 |
| Average Volume | 100,532 |
| Market Cap | 75.24M |
| PE | -3.02 |
| EPS | -0.42 |
| Moving Average 50 Days | 1.12 |
| Moving Average 200 Days | 1.18 |
| Change | -0.02 |
If you invested $1000 in Vivani Medical, Inc. (VANI) 10 years ago, it would be worth $3.78 as of July 01, 2025 at a share price of $1.27. Whereas If you bought $1000 worth of Vivani Medical, Inc. (VANI) shares 5 years ago, it would be worth $423.33 as of July 01, 2025 at a share price of $1.27.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vivani Medical Appoints Anthony Baldor as Chief Financial Officer
GlobeNewswire Inc.
Jun 11, 2025 12:00 PM GMT
ALAMEDA, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the appointment of
Vivani Medical to Present at the 2025 BIO International Convention
GlobeNewswire Inc.
Jun 10, 2025 12:30 PM GMT
ALAMEDA, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mend
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
GlobeNewswire Inc.
May 29, 2025 12:30 PM GMT
Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani and Cortigent stockholders Cortigent is developing the Orion® Visual Cortical Prosthesis System to provide meaningful